CTRS
LIVE

Serial Number

79150591

Owner

LABORATOIRES C.T.R.S.

Attorney

M. Scott Alprin

Filing Date

Apr 10, 2014

Add to watchlist:

No watchlists yet
View on USPTO

CTRS Trademark

Serial Number: 79150591 • Registration: 4783860

CTRS is a trademark filed by LABORATOIRES C.T.R.S. on April 10, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LABORATOIRES C.T.R.S. (6 trademarks)

68 rue de l'Est

Entity Type: 99

Trademark Details

Filing Date

April 10, 2014

Registration Date

August 4, 2015

Published for Opposition

May 19, 2015

Cancellation Date

April 10, 2024

Goods & Services

Pharmaceutical products for the treatment of biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; dietetic substances and foods for medical use, namely, drinks adapted for medical use; antibiotics; capsules for medicines, namely, capsules for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; stem cells for medical use; drugs for medical use, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; medicines for human medicine, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions cancer; bacteriological preparations for medical purposes; biological preparations for medical use, namely, biological preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; chemical preparations for medical or pharmaceutical use, namely, for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; diagnostic products for medical use, namely, medical diagnostic reagents

Medical services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; health counseling services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; consultancy in the field of pharmaceutical products; medical information; information on pharmaceutical products; medical analysis services relating to the treatment of patients affected by biliary insufficiency, cell therapy, inflammatory conditions and diseases, hematology-related and cancer-related conditions and diseases; medical diagnostic services

Medical services featuring evaluations, estimates and research in the field of science; research and development in the field of medicine and biotechnology; research and development for others in the medical and pharmaceutical field; scientific laboratory services in the medical field; scientific research for medical purposes; biological research; bacteriological research; chemical research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 1, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 1, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 20, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 18, 2022 INTS
INVALIDATION PROCESSED
Nov 18, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 18, 2022 INTR
CANCELLED SECTION 71
Feb 18, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 4, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 6, 2016 FICS
FINAL DISPOSITION PROCESSED
Jan 6, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 4, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2015 R.PR
NOTIFICATION PROCESSED BY IB
Jun 12, 2015 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2015 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 29, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2015 PREV
ASSIGNED TO LIE
Apr 11, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2015 TROA
REFUSAL PROCESSED BY IB
Sep 11, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 27, 2014 RFCS
REFUSAL PROCESSED BY MPU
Aug 27, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2014 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 22, 2014 MAFR
ASSIGNED TO EXAMINER
Aug 18, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2014 REPR